VRME vs. AIFF, AIXI, AOGO, MTC, TSRI, NTWK, CLPS, MNDO, FGMC, and VRAR
Should you be buying VerifyMe stock or one of its competitors? The main competitors of VerifyMe include Firefly Neuroscience (AIFF), Xiao-I (AIXI), Arogo Capital Acquisition (AOGO), MMTec (MTC), TSR (TSRI), NetSol Technologies (NTWK), CLPS Incorporation (CLPS), MIND C.T.I. (MNDO), FG Merger (FGMC), and The Glimpse Group (VRAR). These companies are all part of the "computer software" industry.
VerifyMe vs.
Firefly Neuroscience (NASDAQ:AIFF) and VerifyMe (NASDAQ:VRME) are both small-cap business services companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, profitability, media sentiment, analyst recommendations, institutional ownership, risk, valuation, community ranking and dividends.
VerifyMe has a net margin of -13.15% compared to Firefly Neuroscience's net margin of -73.72%. VerifyMe's return on equity of -11.15% beat Firefly Neuroscience's return on equity.
In the previous week, VerifyMe had 9 more articles in the media than Firefly Neuroscience. MarketBeat recorded 9 mentions for VerifyMe and 0 mentions for Firefly Neuroscience. VerifyMe's average media sentiment score of 0.69 beat Firefly Neuroscience's score of -0.95 indicating that VerifyMe is being referred to more favorably in the news media.
VerifyMe has a consensus price target of $1.38, suggesting a potential upside of 89.39%. Given VerifyMe's stronger consensus rating and higher probable upside, analysts clearly believe VerifyMe is more favorable than Firefly Neuroscience.
VerifyMe received 12 more outperform votes than Firefly Neuroscience when rated by MarketBeat users. Likewise, 66.67% of users gave VerifyMe an outperform vote while only 0.00% of users gave Firefly Neuroscience an outperform vote.
Firefly Neuroscience has a beta of 3.22, suggesting that its share price is 222% more volatile than the S&P 500. Comparatively, VerifyMe has a beta of 0.48, suggesting that its share price is 52% less volatile than the S&P 500.
5.0% of Firefly Neuroscience shares are held by institutional investors. Comparatively, 8.8% of VerifyMe shares are held by institutional investors. 8.4% of Firefly Neuroscience shares are held by company insiders. Comparatively, 24.1% of VerifyMe shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Firefly Neuroscience has higher earnings, but lower revenue than VerifyMe. VerifyMe is trading at a lower price-to-earnings ratio than Firefly Neuroscience, indicating that it is currently the more affordable of the two stocks.
Summary
VerifyMe beats Firefly Neuroscience on 14 of the 18 factors compared between the two stocks.
Get VerifyMe News Delivered to You Automatically
Sign up to receive the latest news and ratings for VRME and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
VerifyMe Competitors List
Related Companies and Tools
This page (NASDAQ:VRME) was last updated on 5/22/2025 by MarketBeat.com Staff
Buy VRME Stock Free VRME Stock Alerts